Paper26310932
Retinoid X receptor α enhances human cholangiocarcinoma growth through simultaneous activation of Wnt/β-catenin and nuclear factor-κB pathways.
Huang GL and 5 others. Cancer Sci, 2015. Cited by 24 papers, by iCite.
Cite this record
ConductScience Library. Retinoid X receptor α enhances human cholangiocarcinoma growth through simultaneous activation of Wnt/β-catenin and nuclear factor-κB pathways. Papers, record 26310932. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26310932
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Retinoid X receptor α enhances human cholangiocarcinoma growth through simultaneous activation of Wnt/β-catenin and nuclear factor-κB pathways.
- PubMed
Topics23
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bile Duct Neoplasms | Major topic |
| Cholangiocarcinoma | Major topic |
| Retinoid X Receptor alpha | Major topic |
| Signal Transduction | Major topic |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Blotting, Western | |
| Cell Line, Tumor | |
| Cell Proliferation | |
| Cell Survival | |
| Female | |
| Flow Cytometry | |
| Fluorescent Antibody Technique | |
| Humans | |
| Immunohistochemistry | |
| Male | |
| Middle Aged | |
| NF-kappa B | |
| Real-Time Polymerase Chain Reaction | |
| Transfection | |
| Wnt Proteins | |
| beta Catenin |
Source PubMed
References36
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 14686975 | Retinoids: therapeutic applications and mechanisms of action in cutaneous T-cell lymphoma. | Dermatol Ther | 2003 | https://conductscience.org/library/papers/14686975 | PubMed |
| 2 | 12750559 | Aberration in the expression of the retinoid receptor, RXRalpha, in prostate cancer. | Cancer Biol Ther | 2003 | https://conductscience.org/library/papers/12750559 | PubMed |
| 3 | 22213475 | Amplified in breast cancer 1 enhances human cholangiocarcinoma growth and chemoresistance by simultaneous activation of Akt and Nrf2 pathways. | Hepatology | 2012 | https://conductscience.org/library/papers/22213475 | PubMed |
| 4 | 23919104 | Hilar cholangiocarcinoma. | World J Gastrointest Oncol | 2013 | https://conductscience.org/library/papers/23919104 | PubMed |
| 5 | 21515403 | Modulation of RXR function through ligand design. | Biochim Biophys Acta | 2012 | https://conductscience.org/library/papers/21515403 | PubMed |
| 6 | 20798333 | Nuclear hormone retinoid X receptor (RXR) negatively regulates the glucose-stimulated insulin secretion of pancreatic ß-cells. | Diabetes | 2010 | https://conductscience.org/library/papers/20798333 | PubMed |
| 7 | 23520144 | The challenge of cholangiocarcinoma: dissecting the molecular mechanisms of an insidious cancer. | Dis Model Mech | 2013 | https://conductscience.org/library/papers/23520144 | PubMed |
| 8 | 22484497 | Interference of Frizzled 1 (FZD1) reverses multidrug resistance in breast cancer cells through the Wnt/β-catenin pathway. | Cancer Lett | 2012 | https://conductscience.org/library/papers/22484497 | PubMed |
| 9 | 11902573 | The promise of retinoids to fight against cancer. | Nat Rev Cancer | 2001 | https://conductscience.org/library/papers/11902573 | PubMed |
| 10 | 20379220 | Induced pluripotent stem cells and senescence: learning the biology to improve the technology. | EMBO Rep | 2010 | https://conductscience.org/library/papers/20379220 | PubMed |
| 11 | 16142313 | Immunohistochemical and mutational analyses of Wnt signaling components and target genes in intrahepatic cholangiocarcinomas. | Int J Oncol | 2005 | https://conductscience.org/library/papers/16142313 | PubMed |
| 12 | 20651349 | Inhibition of Wnt signaling pathway decreases chemotherapy-resistant side-population colon cancer cells. | Anticancer Res | 2010 | https://conductscience.org/library/papers/20651349 | PubMed |
| 13 | 21376230 | Hallmarks of cancer: the next generation. | Cell | 2011 | https://conductscience.org/library/papers/21376230 | PubMed |
| 14 | 15520817 | Principles for modulation of the nuclear receptor superfamily. | Nat Rev Drug Discov | 2004 | https://conductscience.org/library/papers/15520817 | PubMed |
| 15 | 17613434 | RXR is an essential component of the oncogenic PML/RARA complex in vivo. | Cancer Cell | 2007 | https://conductscience.org/library/papers/17613434 | PubMed |
| 16 | 11144921 | Expression of p53 and PCNA in cholangiocarcinoma and primary sclerosing cholangitis. | Mod Pathol | 2000 | https://conductscience.org/library/papers/11144921 | PubMed |
| 17 | 23822562 | Inhibition of Wnt/β-catenin signaling downregulates P-glycoprotein and reverses multi-drug resistance of cholangiocarcinoma. | Cancer Sci | 2013 | https://conductscience.org/library/papers/23822562 | PubMed |
| 18 | 11945128 | Discovery and design of retinoic acid receptor and retinoid X receptor class- and subtype-selective synthetic analogs of all-trans-retinoic acid and 9-cis-retinoic acid. | Curr Med Chem | 2002 | https://conductscience.org/library/papers/11945128 | PubMed |
| 19 | 10318916 | The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. | Proc Natl Acad Sci U S A | 1999 | https://conductscience.org/library/papers/10318916 | PubMed |
| 20 | 21561764 | Suppression of retinoid X receptor alpha and aberrant β-catenin expression significantly associates with progression of colorectal carcinoma. | Eur J Cancer | 2011 | https://conductscience.org/library/papers/21561764 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42458135 | Triorganotin compounds as emerging nuclear retinoid X receptor ligands and their implications in cancer. | Biometals | 2026 | https://conductscience.org/library/papers/42458135 | PubMed |
| 40600221 | Expression and Prognostic Implication of the Nuclear Receptors Farnesoid X Receptor and Pregnane X Receptor in Human Cholangiocarcinoma. | Cancer Diagn Progn | 2025 | https://conductscience.org/library/papers/40600221 | PubMed |
| 39326734 | Hepatic Nuclear Receptors in Cholestasis-to-Cholangiocarcinoma Pathology. | Am J Pathol | 2025 | https://conductscience.org/library/papers/39326734 | PubMed |
| 36203481 | Network Toxicology Guided Mechanism Study on the Association between Thyroid Function and Exposures to Polychlorinated Biphenyls Mixture. | Biomed Res Int | 2022 | https://conductscience.org/library/papers/36203481 | PubMed |
| 36114826 | Suppression of intrahepatic cholangiocarcinoma cell growth by SKI via upregulation of the CDK inhibitor p21. | FEBS Open Bio | 2022 | https://conductscience.org/library/papers/36114826 | PubMed |
| 35011625 | The Nuclear Receptor PXR in Chronic Liver Disease. | Cells | 2021 | https://conductscience.org/library/papers/35011625 | PubMed |
| 33523396 | Interaction of NF-κB and Wnt/β-catenin Signaling Pathways in Alzheimer's Disease and Potential Active Drug Treatments. | Neurochem Res | 2021 | https://conductscience.org/library/papers/33523396 | PubMed |
| 31964941 | Long-term Proton Pump Inhibitor Administration Caused Physiological and Microbiota Changes in Rats. | Sci Rep | 2020 | https://conductscience.org/library/papers/31964941 | PubMed |
| 31284679 | Roles of Zinc Finger Protein 423 in Proliferation and Invasion of Cholangiocarcinoma through Oxidative Stress. | Biomolecules | 2019 | https://conductscience.org/library/papers/31284679 | PubMed |
| 31118667 | Retinoic acid receptor α facilitates human colorectal cancer progression via Akt and MMP2 signaling. | Onco Targets Ther | 2019 | https://conductscience.org/library/papers/31118667 | PubMed |
| 30915350 | Tankyrase Promotes Aerobic Glycolysis and Proliferation of Ovarian Cancer through Activation of Wnt/β-Catenin Signaling. | Biomed Res Int | 2019 | https://conductscience.org/library/papers/30915350 | PubMed |
| 30216632 | The nuclear receptor RXRA controls cellular senescence by regulating calcium signaling. | Aging Cell | 2018 | https://conductscience.org/library/papers/30216632 | PubMed |
| 28272990 | Oncogenic retinoic acid receptor γ knockdown reverses multi-drug resistance of human colorectal cancer via Wnt/β-catenin pathway. | Cell Cycle | 2017 | https://conductscience.org/library/papers/28272990 | PubMed |
| 28237397 | SOX17 regulates cholangiocyte differentiation and acts as a tumor suppressor in cholangiocarcinoma. | J Hepatol | 2017 | https://conductscience.org/library/papers/28237397 | PubMed |
| 26310932 | Retinoid X receptor α enhances human cholangiocarcinoma growth through simultaneous activation of Wnt/β-catenin and nuclear factor-κB pathways. | Cancer Sci | 2015 | https://conductscience.org/library/papers/26310932 | PubMed |
Genes19
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26310932
GET https://conductscience.org/api/papers/v1/26310932/references?page=2